FDA Approves 2nd Gene Therapy

THURSDAY, Oct. 19, 2017 -- The U.S. Food and Drug Administration has approved the second gene therapy for use in the United States.
The new treatment, Yescarta (axicabtagene ciloleucel), is for a kind of blood cancer called large B-cell...